Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Simons

Showing results (231-240 of 364) with videos related to

Pageof 37
Sort By:
Translational Psychiatry|July 23, 2025
Pharmacologic and genetic evidence converge on mechanisms of psychotic illnessBrian Fennessy, Liam Cotter, Nicole W Simons, et al.
Cancer Research|April 5, 2000
Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeuticsH Zhong, K Chiles, D Feldser, et al.
BJU International|December 24, 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicityAshley E Ross, Ashkan Emadi, Luigi Marchionni, et al.
Oncotarget|July 5, 2012
Sox9 is required for prostate development and prostate cancer initiationZhenhua Huang, Paula J Hurley, Brian W Simons, et al.
Cytometry|June 17, 1998
Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancerC G Healy, J W Simons, M A Carducci, et al.
Urology|January 14, 1999
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinomaM A Carducci, S Piantadosi, C R Pound, et al.
The American Journal of Medicine|February 8, 1985
Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumoniaJ J Schentag, A J Vari, N E Winslade, et al.
Nature Medicine|September 1, 1995
Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostateJ B Nelson, S P Hedican, D J George, et al.
Journal of the National Cancer Institute|February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancerM G Sanda, N P Restifo, J C Walsh, et al.
Cancer Research|May 1, 2002
Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cellsNicola J Mabjeesh, Dawn E Post, Margaret T Willard, et al.
Pageof 37

Showing results (231-240 of 364) with videos related to

Sort By:
Pageof 37
Translational Psychiatry|July 23, 2025
Pharmacologic and genetic evidence converge on mechanisms of psychotic illnessBrian Fennessy, Liam Cotter, Nicole W Simons, et al.
Cancer Research|April 5, 2000
Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeuticsH Zhong, K Chiles, D Feldser, et al.
BJU International|December 24, 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicityAshley E Ross, Ashkan Emadi, Luigi Marchionni, et al.
Oncotarget|July 5, 2012
Sox9 is required for prostate development and prostate cancer initiationZhenhua Huang, Paula J Hurley, Brian W Simons, et al.
Cytometry|June 17, 1998
Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancerC G Healy, J W Simons, M A Carducci, et al.
Urology|January 14, 1999
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinomaM A Carducci, S Piantadosi, C R Pound, et al.
The American Journal of Medicine|February 8, 1985
Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumoniaJ J Schentag, A J Vari, N E Winslade, et al.
Nature Medicine|September 1, 1995
Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostateJ B Nelson, S P Hedican, D J George, et al.
Journal of the National Cancer Institute|February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancerM G Sanda, N P Restifo, J C Walsh, et al.
Cancer Research|May 1, 2002
Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cellsNicola J Mabjeesh, Dawn E Post, Margaret T Willard, et al.
Pageof 37